Published in Clinical Trials Week, September 5th, 2005
"Levocetirizine is a potent and highly selective H1-antihistamine with a proven efficacy in adults," pediatricians in France explained.
"Studies evaluating newer antihistamines in children are few," noted J. de Blic and colleagues working at the Hôpital des Enfants Malades in Paris, who evaluated "the efficacy of levocetirizine 5 mg once-daily" in reducing SAR symptoms, "as measured by Total Four Symptom Score (T4SS=sum of sneezing, rhinorrhea, nasal and ocular pruritus), over the first 2 wk of treatment."
In addition...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2005-09-05)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.